Global report - October 3, 2025
CaixaResearch Institute – A key player in Barcelona’s life science hub
Investment in science drives societal progress. Barcelona has been doing its part for more than two decades and is now demonstrating its commitment with the construction of the CaixaResearch Institute – a center that aspires to become a benchmark in immunological diseases.
Global report - September 30, 2025
New Trump campaign on tariffs shows that the EU’s internal market must be strengthened, states SwedenBIO
President Trump recently announced that trademarked or patented pharmaceutical products will be subject to a 100 percent tariff starting October 1, 2025 – unless the manufacturer establishes a production facility in the United States. The latest move reinforces the uncertainty that the life sciences industry is already experiencing and raises a number of questions about […]
Global report - September 29, 2025
AstraZeneca switch to direct US listing, keeps UK listing
AstraZeneca plans to harmonize its share listing structure to deliver "a global listing for global investors in a global company".
Global report - September 22, 2025
Pfizer to acquire Metsera and its next-generation obesity portfolio
Pfizer will acquire all outstanding shares of Metsera common stock for USD 47.50 per share in cash at closing, representing an enterprise value of approximately USD 4.9 billion.
Collaboration - September 18, 2025
European partnership against antibiotic resistance to be launched
The European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) will be launched at an event in Brussels on September 23.
Global report - August 22, 2025
EU, US trade statement: 15% tariffs on pharmaceuticals
The joint statement, released yesterday, confirms that cars, semiconductors, and pharmaceuticals will face a maximum 15% tariffs to enter the US.
